Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Dhar

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Journal of Bacteriology|October 1, 2013
Phenotypic profiling of Mycobacterium tuberculosis EspA point mutants reveals that blockage of ESAT-6 and CFP-10 secretion in vitro does not always correlate with attenuation of virulenceJeffrey M Chen, Ming Zhang, Jan Rybniker, et al.
Journal of Bacteriology|December 14, 2011
EspD is critical for the virulence-mediating ESX-1 secretion system in Mycobacterium tuberculosisJeffrey M Chen, Stefanie Boy-Röttger, Neeraj Dhar, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2014
Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosisSreevalli Sharma, Ekaterina Gelman, Chandan Narayan, et al.
Frontiers in Cellular and Infection Microbiology|September 11, 2023
Amidation of glutamate residues in mycobacterial peptidoglycan is essential for cell wall cross-linkingMoagi T Shaku, Karl L Ocius, Alexis J Apostolos, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2014
In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosisMing Zhang, Claudia Sala, Neeraj Dhar, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2014
Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibioticNeeraj Dhar, Vincent Dubée, Lluis Ballell, et al.
Scientific Reports|April 27, 2017
An Amidase_3 domain-containing N-acetylmuramyl-L-alanine amidase is required for mycobacterial cell divisionSibusiso Senzani, Dong Li, Ashima Bhaskar, et al.
Vaccine|October 20, 2009
Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigsBappaditya Dey, Ruchi Jain, Aparna Khera, et al.
Vaccine|September 15, 2005
Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosisAparna Khera, Ramandeep Singh, H Shakila, et al.
Plos One|December 5, 2008
Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lungRuchi Jain, Bappaditya Dey, Neeraj Dhar, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Journal of Bacteriology|October 1, 2013
Phenotypic profiling of Mycobacterium tuberculosis EspA point mutants reveals that blockage of ESAT-6 and CFP-10 secretion in vitro does not always correlate with attenuation of virulenceJeffrey M Chen, Ming Zhang, Jan Rybniker, et al.
Journal of Bacteriology|December 14, 2011
EspD is critical for the virulence-mediating ESX-1 secretion system in Mycobacterium tuberculosisJeffrey M Chen, Stefanie Boy-Röttger, Neeraj Dhar, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2014
Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosisSreevalli Sharma, Ekaterina Gelman, Chandan Narayan, et al.
Frontiers in Cellular and Infection Microbiology|September 11, 2023
Amidation of glutamate residues in mycobacterial peptidoglycan is essential for cell wall cross-linkingMoagi T Shaku, Karl L Ocius, Alexis J Apostolos, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2014
In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosisMing Zhang, Claudia Sala, Neeraj Dhar, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2014
Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibioticNeeraj Dhar, Vincent Dubée, Lluis Ballell, et al.
Scientific Reports|April 27, 2017
An Amidase_3 domain-containing N-acetylmuramyl-L-alanine amidase is required for mycobacterial cell divisionSibusiso Senzani, Dong Li, Ashima Bhaskar, et al.
Vaccine|October 20, 2009
Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigsBappaditya Dey, Ruchi Jain, Aparna Khera, et al.
Vaccine|September 15, 2005
Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosisAparna Khera, Ramandeep Singh, H Shakila, et al.
Plos One|December 5, 2008
Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lungRuchi Jain, Bappaditya Dey, Neeraj Dhar, et al.
Pageof 8